The Cost of Cancer Care: Navigation Challenges to Participation in Phase I Clinical Trials

Wanda Strange, Shannon Cagnina, Cynthia Bedell, John J. Nemunaitis


Phase I trial participation for advanced cancer patients is often a “last resort” in an attempt to control progressive disease. It is also a necessary component mandated by our investigative community and FDA to characterize safety and mechanism via dose and schedule modulation of experimental therapeutics. Participation in phase I studies is difficult without support. The purpose of this assessment is to provide mechanisms of support established by nurse navigation to facilitate phase I trial patient participation.

Full Text:




  • There are currently no refbacks.

Cancer and Clinical Oncology ISSN 1927-4858(Print) ISSN 1927-4866(Online)

Copyright © Canadian Center of Science and Education

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.